Obalon_Logo_Teal_2c.jpg
Obalon Announces Third Quarter 2017 Financial Results
03 nov. 2017 07h29 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 03, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Therapeutics, Inc. and Sono Bello Announce Agreement to Offer Novel Weight Loss Treatment in Sono Bello Centers
02 nov. 2017 16h06 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) and Sono Bello announced today that they had reached an agreement to begin offering the novel Obalon Balloon...
Obalon_Logo_Teal_2c.jpg
Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time
26 oct. 2017 08h01 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
Obalon_Logo_Teal_2c.jpg
Kelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive Team
07 sept. 2017 08h58 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Kelly Huang, Ph.D., has joined as its...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Second Quarter 2017 Financial Results
02 août 2017 07h59 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Upcoming Conference Presentation
31 juil. 2017 08h45 HE | Obalon Therapeutics, Inc.
SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Schedules Second Quarter 2017 Financial Results Conference Call for August 2, 2017 at 8:30 a.m. Eastern Time
27 juil. 2017 07h50 HE | Obalon Therapeutics, Inc.
SAN DIEGO, July 27, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Therapeutics, Inc. to Present at UBS Global Healthcare Conference
22 mai 2017 09h05 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
11 mai 2017 08h02 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
11 mai 2017 08h02 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...